ENZO BIOCHEM INC
0.00%
0
316253
294100102
Aug 19, 2025
Aug 22, 2025, 11:30 AM
Reporting Persons (2)
This is a joint filing. The reported shares may overlap between reporting persons and should not be summed.
| Name | Type | % of Class | Aggregate | Sole Voting | Shared Voting |
|---|---|---|---|---|---|
| Radoff Family Foundation | CO | 0.00% | 0 | 0 | 0 |
| Radoff Bradley Louis | Individual | 0.00% | 0 | 0 | 0 |
Disclosure Items (3)
Common Stock, par value $0.01 per share
ENZO BIOCHEM INC
60 EXECUTIVE BLVD, FARMINGDALE, NY, 11735
Item 5(a) is hereby amended and restated to read as follows: Effective August 20, 2025, as a result of the Merger, each Share owned by the Reporting Persons was converted into the Merger Consideration, and each RSU owned by the Reporting Persons was canceled and converted into the right to receive an amount in cash obtained by multiplying (i) the total number of Shares underlying such RSU, by (ii) the Merger Consideration, subject to any withholding of taxes. Accordingly, the Reporting Persons no longer beneficially own any securities of the Issuer.
Item 5(b) is hereby amended and restated to read as follows: Effective August 20, 2025, as a result of the Merger, each Share owned by the Reporting Persons was converted into the Merger Consideration, and each RSU owned by the Reporting Persons was canceled and converted into the right to receive an amount in cash obtained by multiplying (i) the total number of Shares underlying such RSU, by (ii) the Merger Consideration, subject to any withholding of taxes. Accordingly, the Reporting Persons no longer beneficially own any securities of the Issuer.
Item 5(c) is hereby amended and restated to read as follows: Except as otherwise set forth in Item 4, there have been no transactions in the securities of the Issuer by the Reporting Persons since the filing of Amendment No. 5 to the Schedule 13D.
Item 5(e) is hereby amended and restated to read as follows: As of August 20, 2025, the Reporting Persons ceased to beneficially own more than 5% of the outstanding Shares.